The IPD and IMGT/HLA database: allele variant databases.

Robinson J, Halliwell JA, Hayhurst JD, Flicek P, Parham P, Marsh SG. · 2015

Read The IPD and IMGT/HLA database: allele variant databases. by Robinson J, Halliwell JA, Hayhurst JD, Flicek P, Parham P, Marsh SG. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4383959.txt.

Introduction

James Robinson, Jason Halliwell, James Hayhurst, Paul Flicek, Peter Parham, and Steven Marsh described the immune polymorphism databases in Nucleic Acids Research in 2015. Genes of the immune system, above all the HLA genes that govern tissue matching, vary enormously between people. The Immuno Polymorphism Database project gathers that variation into one curated platform. Specialist nomenclature committees check each section before it is published online.

The project holds five core databases, headed by the IMGT/HLA database, the main reference for HLA variants used in transplant matching. Partner groups include the HLA Informatics Group and the European Bioinformatics Institute. New tools respond to next-generation sequencing, which produces variant data at new scale, and to user requests. Regular updates push new and confirmed sequences out to immunogenetics and clinical users quickly.

Catalog record

CREATORRobinson J, Halliwell JA, Hayhurst JD, Flicek P, Parham P, Marsh SG.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4383959

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The IPD and IMGT/HLA database: allele variant databases By James Robinson, Jason A Halliwell, James D Hayhurst, Paul Flicek, Peter Parham, Steven G E Marsh Published in: Nucleic Acids Research DOI: 10.1093/nar/gku1161 ABSTRACT Abstract The Immuno Polymorphism Database (IPD) was developed to provide a centralized system for the study of polymorphism in genes of the immune system. Through the IPD project we have established a central platform for the curation and publication of locus-specific databases involved either directly or related to the function of the Major Histocompatibility Complex in a number of different species. We have collaborated with specialist groups or nomenclature committees that curate the individual sections before they are submitted to IPD for online publication. IPD consists of five core databases, with the IMGT/HLA Database as the primary database. Through the work of the various nomenclature committees, the HLA Informatics Group and in collaboration with the European Bioinformatics Institute we are able to provide public access to this data through the website http://www.ebi.ac.uk/ipd/. The IPD project continues to develop with new tools being added to address scientific developments, such as Next Generation Sequencing, and to address user feedback and requests. Regular updates to the website ensure that new and confirmatory sequences are dispersed to the immunogenetics community, and the wider research and clinical communities. INTRODUCTION The Immuno Polymorphism Database (IPD) comprises a set of specialist databases related to the study of polymorphic genes in the immune system. Through the IPD project (1) we collaborate with specialist groups or nomenclature committees that provide and curate individual sections before they are submitted to IPD for online publication. The IPD project stores all the data in a set of related databases. IPD currently consists of five databases: IMGT/HLA, which contains sequences of the human Major Histocompatibility Complex (MHC); IPD-KIR, which contains the allelic sequences of the human Killer-cell Immunoglobulin-like Receptors; IPD-MHC, which is a database of sequences of the MHC of different species; IPD-HPA, which is a database of human platelet antigens; and IPD-ESTDAB, which provides access to the European Searchable Tumour Cell-Line Database, a cell bank of immunologically characterized melanoma cell lines. ALLELE DATABASES A central function of the IPD project is as a database repository for the sequence data of polymorphic gene sequences. The project connects nomenclature committees for polymorphic gene systems with a core bioinformatics team who develop the tools and infrastructure required to maintain and publish the data. The aim of the project is to facilitate the work of the various nomenclature committees defining and curating the alleles within each gene system. Each allele is defined as a unique nucleotide sequence stored in the database and may cover the full-length of the gene, from UTR to UTR or just a mandatory number of exons. The entries in the database are not a description comparing two sequences. The submissions of a novel sequence must contain the sequence, and details of how this was obtained. A variant cannot not be reported as a Single Nucleotide Polymorphism (SNP) at a single position compared to a reference, without submitting proof of the sequence, the methodology used to obtain the sequence and details of the sample and its source. This ensures that the alleles seen in the databases are restricted to verified sequences and not a dataset of theoretical combinations of SNPs. THE IMGT/HLA DATABASE The IMGT/HLA Database was established to provide a locus-specific database (LSDB) for the allelic sequences of the genes in the HLA system, also known as the human MHC. The IMGT/HLA Database was first released in 1998 and subsequently incorporated as a module of IPD in 2012. The MHC is one of the most complex and polymorphic regions of the human genome, with in excess of 220 genes (2). The core genes of interest in the HLA system are 21 polymorphic HLA genes, found within the 6p21.3 region of the short arm of human chromosome 6, whose protein products mediate human responses to infectious disease and influence the outcome of cell and organ transplants. The level of polymorphism seen in some of the genes is very high, with over 3000 variants seen in HLA-B; this level of variation can be considered hyper-polymorphic when compared to other gene systems. Three distinct regions have been identified within the MHC. The class I region is located at the telomeric end of the MHC and encodes the genes for the HLA class I molecules, HLA-A, -B and -C. These are co-dominantly expressed on the cell surface, and are responsible for presenting intracellularly derived peptides to CD8 positive T cells. The class II region lies at the centromeric end of the MHC and encodes HLA class II genes HLA-DRA, -DRB1, -DRB3, -DRB4, -DRB5, -DQA1, -DQB1, -DPA1 and -DPB1. HLA class II expression is limited to professional antigen presenting cells, where these molecules present extracellularly derived peptides to CD4 positive T cells. Located between the class I and class II regions lies the class III region where a number of non-HLA genes with immune function are located. With a nomenclature covering more than 50 genes and 12 000 alleles, there is an obvious need for a curated LSDB to manage these highly polymorphic variants. The first public release of the IMGT/HLA Database was made on the 16 December 1998 (3). Since then the database has been updated every three months, in a total of 64 releases, (Figure 1), to include all the publicly available sequences officially named by the WHO Nomenclature Committee at the time of release. [Figure: Growth of the IMGT/HLA Database. The number of allele sequences deposited annually in the IMGT/HLA Database is shown for class I (green), class II (black). The slope of the line reflects the rate of acquisition, which has accelerated in recent years.] A major driving force behind the development and continued success of the IMGT/HLA Database is its use by the transplantation community. The HLA molecules play a key role in transplantation, with the success of kidney and bone marrow transplantation correlated with the degree to which donors and recipient are HLA matched. It has been shown that HLA matching is a critical determinant of outcome for patients receiving unrelated donor haematopoietic stem cells for haematological disorders (4). This has led to progressive improvements in the level of resolution achieved by HLA class I and II typing methods. HLA typing now focuses on distinguishing synonymous and non-synonymous differences within the nucleotide sequences that encode the protein domains of HLA class I and II molecules. These are the peptide binding domains that interact with variable lymphocyte receptors. The consequence of these improvements has required the development, for each polymorphic HLA class I and II gene, of a nucleotide sequence database that is both accurate and comprehensive. The use of a generalist sequence database for storing these sequences can be problematic due to inconsistencies in keyword descriptions, erroneous sequences and uncorrected errors. The outcome and success of a transplant could be affected by a single SNP between the recipient and the donor. It is therefore vital for any repository storing HLA sequences to have high standards of both quality control and curation. To this end all sequences submitted to the IMGT/HLA Database are expected to meet a minimum set

Read the complete text